2'-hydroxyflavanone has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumi, K; Kadono, Y; Keller, ET; Kitagawa, Y; Konaka, H; Kumaki, M; Mizokami, A; Namiki, M; Ofude, M; Shin, M; Zhang, J | 1 |
1 other study(ies) available for 2'-hydroxyflavanone and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2'-hydroxyflavanone.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Active Transport, Cell Nucleus; Androgens; Androstenedione; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Estradiol Dehydrogenases; Flavanones; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; Male; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen | 2013 |